| RS1569190079 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase complex deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1569190422 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1569190602 |
RPS6KA3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 19 |
| RS1569190962 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1569191372 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1569191659 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1569191879 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1569192251 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS1569192315 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS1569194036 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1569194162 |
RPS6KA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Lowry syndrome, Intellectual disability |
| RS1569197778 |
USP51
|
Health Risk |
Pathogenic |
Short stature, Short stature |
| RS1569198407 |
NEFH
|
Health Risk |
Pathogenic |
— |
| RS1569200407 |
ZC4H2
|
Health Risk |
Likely pathogenic |
— |
| RS1569201595 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1569203234 |
CRYBB1
|
Health Risk |
Pathogenic |
Cataract 17 multiple types, Cataract 17 multiple types |
| RS1569203272 |
MEI1
|
Health Risk |
Pathogenic |
Hydatidiform mole, recurrent |
| RS1569203705 |
IL1RAPL1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 21 |
| RS1569206815 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1569208908 |
IL1RAPL1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 21 |
| RS1569211016 |
OPHN1
|
Health Risk |
Pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS1569213054 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1569213903 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569213917 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1569214985 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1569215025 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1569215061 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease |
| RS1569215212 |
GJB1
|
Health Risk |
Pathogenic |
— |
| RS1569215263 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS1569215346 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease |
| RS1569215351 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease |
| RS1569215382 |
OPHN1
|
Health Risk |
Pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS1569215413 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1569215418 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS1569215424 |
GJB1
|
Health Risk |
Likely pathogenic |
— |
| RS1569215443 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1569215591 |
GJB1
|
Health Risk |
Likely pathogenic |
— |
| RS1569215594 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1569215629 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1569215645 |
CDKL5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569215664 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS1569215808 |
OPHN1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569216119 |
RPS6KA3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 19 |
| RS1569216588 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1569218019 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1569218064 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1569218119 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1569218416 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1569219331 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1569219346 |
CDKL5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569219844 |
CDKL5
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1569220550 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569220754 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
CDKL5 disorder, CDKL5 disorder |
| RS1569220925 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1569225454 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1569226110 |
CELSR1
|
Health Risk |
Likely pathogenic |
Lymphatic malformation, Lymphatic malformation |
| RS1569227576 |
CELSR1
|
Health Risk |
Likely pathogenic |
Lymphatic malformation 9, Lymphatic malformation |
| RS1569229528 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569229724 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 2 |
| RS1569230006 |
CLCN4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 49 |
| RS1569230215 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569230293 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569230389 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569230406 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569230484 |
CLCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1569231336 |
CDKL5
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS1569231897 |
CLCN4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 49 |
| RS1569232705 |
DEPDC5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Familial focal epilepsy with variable foci |
| RS1569233549 |
CLCN4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 49 |
| RS1569234334 |
KIF4A
|
Health Risk |
Likely pathogenic |
Corpus callosum, agenesis of |
| RS1569234653 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS1569235565 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS1569235677 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 3, X-linked cone-rod dystrophy 1 |
| RS1569235803 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1569235999 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, RPGR-related retinopathy |
| RS1569236609 |
RPGR
|
Health Risk |
Pathogenic |
— |
| RS1569236971 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, RPGR-related retinopathy |
| RS1569237077 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS1569237206 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa |
| RS1569237670 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS1569238002 |
DDX3X
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS1569238251 |
DDX3X
|
Health Risk |
Likely pathogenic |
— |
| RS1569238659 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS1569239749 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1569240005 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS1569240261 |
DDX3X
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569242061 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts |
| RS1569242657 |
BRWD3
|
Health Risk |
Pathogenic |
— |
| RS1569243565 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS1569243771 |
PLA2G6
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 2B, Neurodegeneration with brain iron accumulation 2B |
| RS1569243931 |
OPHN1
|
Health Risk |
Pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS1569244149 |
MLC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1569244190 |
MLC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1569244467 |
OPHN1
|
Health Risk |
Pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS1569245569 |
BRWD3
|
Health Risk |
Pathogenic |
— |
| RS1569248367 |
MLC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1569249294 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS1569249386 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1569254004 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1569255443 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |